19/05/2013 03:57:11 Free Membership Login
Artes Medical (MM)
   

   

Artes Medical, Incorporated

Visual Financials
Artes Medical stock quote | Artes Medical company information | Artes Medical Stock Chart | Artes Medical Stock News
Company Name: Artes Medical, Incorporated
Ticker Symbol: ARTE
WWW Address: www.artesmedical.com
CEO: Christopher J. Reinhard
No. of Employees: 155
Common Issue Type: CS
Business Description:A medical technology company focused on developing, manufacturing and commercializing a new category of injectable aesthetic products for the dermatology and plastic surgery markets.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 0.03 Unchanged 0.0 - -  0.04 0.03 -
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 0.6 19.7 0.60 -1.63 0.00 0.0 0.0 3.34 - 0.01
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close0.03$
PE Ratio - LTM0.0
Market Capitalisation0.6mil
Latest Shares Outstanding19.7mil
Earnings pS (EPS)-1.63$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee85,910$
Effective Tax Rate0.0%
Float19.5mil
Float as % of Shares Outstanding98.7%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue335.70%
Research & Devlopment (R&D) as % of Revenue107.60%
Gross Profit Margin8.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Assets Turnover0.3%
Return on Assets (ROA)-207.8%
Return on Equity (ROE)0.0%
Return on Capital Invested (ROCI)1294.9%
Current Ratio1.5
Leverage Ratio (Assets/Equity)0.0
Interest Cover0.0
Total Debt/Equity (Gearing Ratio)0.00
LT Debt/Total Capital0.0%
Working Capital pS0.23$
Cash pS0.30$
Book-Value pS0.00$
Tangible Book-Value pS-0.53$
Cash Flow pS-2.17$
Free Cash Flow pS-1.55$
KEY FIGURES (LTM): Price info
Price/Book Ratio0.00
Price/Tangible Book Ratio-0.06
Price/Cash Flow0.0
Price/Free Cash Flow0.0
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---0.0971,866
4 Weeks0.580.010.55-94.552,56043,512
13 Weeks1.250.010.96-96.9498861,266
26 Weeks2.250.011.20-97.54925115,602
52 Weeks3.340.012.37-98.72812202,268
YTD3.340.01--98.72790188,921
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
0.030.040.581.031.130.600.63
 
GROWTH RATES5-Year
Growh		R² of 5-Year Growth3-Year
Growth
Revenue0.000.00.00
Income0.000.00.00
Dividend0.000.00.00
Capital Spending0.00NA-30.47
R&D0.00NA4.30
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD		Curr Qtr vs.
Qtr 1-Yr ago		Annual vs.
Last Annual
Revenue %-35.2-66.40.0
Earnings %0.00.00.0
EPS %0.00.00.0
EPS $-1.110.0812.60
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio46.16
Current Ratio2.5
Quick Ratio (Acid Test)1.9
Liquidity Ratio (Cash)1.82
Receivables Turnover33.6
Average Collection Period11
Working Capital/Equity80.0
Working Capital pS1.00
Cash-Flow pS-1.47
Free Cash-Flow pS-1.51
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio-2.51
Financial Leverage Ratio (Assets/Equity)1.7
Debt Ratio42.3
Total Debt/Equity (Gearing Ratio)0.41
LT Debt/Equity0.11
LT Debt/Capital Invested17.2
LT Debt/Total Liabilities14.8
Interest Cover0.0
Interest/Capital Invested4.56
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.06
Tobin's Q Ratio0.02
Current P/E Ratio - LTM0.00
Enterprise Value (EV)/EBITDA0.18
Enterprise Value (EV)/Free Cash Flow0.26
Dividend Yield0.0
Price/Tangible Book Ratio - LTM-0.06
Price/Book Ratio - LTM0.00
Price/Cash Flow Ratio0.0
Price/Free Cash Flow Ratio - LTM0.0
Price/Sales Ratio0.06
P/E Ratio (1 month ago) - LTM0.0
P/E Ratio (26 weeks ago) - LTM0.0
P/E Ratio (52 weeks ago) - LTM0.0
5-Y High P/E Ratio0.0
5-Y Low P/E Ratio0.0
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E
P/E as % of Industry Group0.0
P/E as % of Sector Segment0.0
Current 12 Month Normalized P/E Ratio - LTM0.0
PER SHARE FIGURES
LT Debt pS0.14
Current Liabilities pS0.68
Tangible Book Value pS - LTM-0.53
Book Value pS - LTM0.00
Capital Invested pS1.16
Cash pS - LTM0.30
Cash Flow pS - LTM-2.17
Free Cash Flow pS - LTM-1.55
Earnings pS (EPS)-1.63
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin-186.87
Free Cash Flow Margin 5YEAR AVG-37.37
Net Profit Margin0.0
Net Profit Margin - 5YEAR AVRG.0.0
Equity Productivity0.65
Return on Equity (ROE)0.0
Return on Equity (ROE) - 5YEAR AVRG.0.0
Capital Invested Productivity0.58
Return on Capital Invested (ROCI)-117.6
Return on Capital Invested (ROCI) - 5YEAR AVRG.0.0
Assets Productivity0.30
Return on Assets (ROA)-75.3
Return on Assets (ROA) - 5YEAR AVRG.0.0
Gross Profit Margin8.0
Gross Profit Margin - 5YEAR AVRG.0.0
EBITDA Margin - LTM0.0
EBIT Margin - LTM0.0
Pre-Tax Profit Margin0.0
Pre-Tax Profit Margin - 5YEAR AVRG.0.0
Effective Tax Rate2.0
Effective Tax Rate - 5YEAR AVRG.1.9
EFFICIENCY RATIOS
Cash Conversion Cycle252
Revenue per Employee85,910
Net Income per Employee-173,452
Average Collection Period21
Receivables Turnover33.6
Day's Inventory Turnover Ratio231
Inventory Turnover1.6
Inventory/Sales41.5
Accounts Payble/Sales23.51
Assets/Revenue3.33
Net Working Capital Turnover0.81
Fixed Assets Turnover1.65
Total Assets Turnover0.3
Revenue per $ Cash0.66
Revenue per $ Plant2.65
Revenue per $ Common Equity0.65
Revenue per $ Capital Invested0.58
Selling, General & Adm/tive (SG&A) as % of Revenue182.7
SG&A Expense as % of Revenue - 5YEAR AVRG.0.0
Research & Devlopment (R&D) as % of Revenue45.2
R&D Expense as % of Revenue - 5YEAR AVRG.45.2

  


NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's

1 site:2 us nasdaq arte130519 03:57